SEC Tracker
Get the app

Bambusa Therapeutics BBTX

Bambusa Therapeutics: S-1MEF filing

S-1MEF filing

Form
S-1MEF
Filed
Importance
Routine
  1. Includes 1,357,638 shares of common stock
  2. 177,083 shares from underwriters option
  3. 20% of max offering price from prior filing

Written from the S-1MEF on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bambusa Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX